Login to Your Account



CHMP's Latest Opinions: Seven Positive, One Negative

By Catherine Shaffer
Staff Writer

Monday, March 25, 2013

The European Medicines Agency's Committee for Medicinal Products for Human use issued opinions for eight drugs of interest to the biopharma sector, including thumbs up for multiple sclerosis (MS) drugs from Biogen Idec Inc. and Genzyme Corp.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription